Front. Med. Frontiers in Medicine Front. Med. 2296-858X Frontiers Media S.A. 10.3389/fmed.2026.1778742 Correction Correction: Association of glucagon-like peptide-1 (GLP-1) receptor agonists and diabetic retinopathy (DR) – a systematic review and meta-analysis Alwafi Hassan 1 * Al-Harbi Sarah Saleh 2 Aladwani Ghada Ahmad 2 Alsanosi Safaa M. 1 Oyelade Tope 3 Almalki Fahd 4 Thalib Husna Irfan 5 Naser Abdallah Y. 6 Alfahmi Manal Z. 7 AlOtaibi Basil 8 Fuad Samra 5 Zubair Mohammed Talha Mohammed 5 Aldhahir Abdulelah M. 9 Insani Widya N. 10 Alqarni Abdullah A. 11 Alqahtani Jaber S. 12 Ashoor Deema S. 13 Dairi Mohammad Saleh 4 Department of Pharmacology and Toxicology, College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia Department of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia Institute for Liver and Digestive Health, UCL Division of Medicine, University College London, London, United Kingdom Department of Medicine, College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia General Medicine Practice Program, Batterjee Medical College, Jeddah, Saudi Arabia Department of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, Amman, Jordan Executive Administration of Research and Innovation, King Abdallah Medical City, Makkah, Saudi Arabia Independent Researcher, Jeddah, Saudi Arabia Respiratory Therapy Program, Department of Nursing, College of Nursing and Health Sciences, Jazan University, Jazan, Saudi Arabia Department of Pharmacology and Clinical Pharmacy, Padjadjaran University, Jatinangor, Indonesia Department of Respiratory Therapy, Faculty of Medical Rehabilitation Sciences, King Abdulaziz University, Jeddah, Saudi Arabia Department of Respiratory Care, Prince Sultan Military College of Health Sciences, Dammam, Saudi Arabia Al-Noor Specialist Hospital, Ministry of Health, Makkah, Saudi Arabia Correspondence: Hassan Alwafi, hhwafi@uqu.edu.sa 05 02 2026 2026 13 1778742 31 12 2025 21 01 2026 Copyright © 2026 Alwafi, Al-Harbi, Aladwani, Alsanosi, Oyelade, Almalki, Thalib, Naser, Alfahmi, AlOtaibi, Fuad, Zubair, Aldhahir, Insani, Alqarni, Alqahtani, Ashoor and Dairi. 2026 Alwafi, Al-Harbi, Aladwani, Alsanosi, Oyelade, Almalki, Thalib, Naser, Alfahmi, AlOtaibi, Fuad, Zubair, Aldhahir, Insani, Alqarni, Alqahtani, Ashoor and Dairi https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. A Correction on Association of glucagon-like peptide-1 (GLP-1) receptor agonists and diabetic retinopathy (DR) – a systematic review and meta-analysis by Alwafi, H., Al-Harbi, S. S., Aladwani, G. A., Alsanosi, S. M., Oyelade, T., Almalki, F., Thalib, H. I., Naser, A. Y., Alfahmi, M. Z., AlOtaibi, B., Fuad, S., Zubair, M. T. M., Aldhahir, A. M., Insani, W. N., Alqarni, A. A., Alqahtani, J. S., Ashoor, D. S., and Dairi, M. S. (2025). Front. Med. 12:1639704. doi: 10.3389/fmed.2025.1639704 GLP-1 agonist diabetes obesity diabetic retinopathy meta-analysis systematic review section-at-acceptance Ophthalmology

Author Safaa M. Alsanosi was erroneously assigned to affiliation BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom. This affiliation has now been removed for author Safaa M Alsanosi.

The original version of this article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland